Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE
HEFEI, China, April 28, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved Phase IIb clinical trial of KPG-818...
Malaysia Aviation Group Achieves Positive NIAT of RM54mil and Third Consecutive Operating Profit on the Back of Operational Headwinds
Positive EBITDA at RM788mil with Operating Profit at RM113mil Stronger load factor, averaging 80%, a 3-percentage point increase from 2023 KUALA LUMPUR, Malaysia, April 24, 2025 /PRNewswire/ -- Malaysia Aviation Group ("MAG" or "the Group") reports...
USANA Philippines Named Among Most Trusted Brands by Reader's Digest
Second consecutive year USANA won gold award in Natural Food Supplements category MANILA, Philippines, April 24, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in cellular nutrition, announced today that its Philippines market...
Yatsen Group Wins "ESG Award" at BeautyInc Awards for Sustainability Leadership in Beauty Industry
SHANGHAI, April 17, 2025 /PRNewswire/ -- Recently, the "Grow with Beauty" Beauty Industry Summit and the 6th BeautyInc Awards Ceremony were held in Shanghai, China. The BeautyInc Awards, launched by BeautyInc — the beauty media brand under the...
Global Health Innovators recognised with Abu Dhabi Global Health Week Innovation Awards for transformative impact
Winners of the ADGHW Innovation Awards 2025 addressed prenatal gene editing, robotic organ transplantation, precision drug delivery, and novel pain treatments Recipients include the Children's Hospital of Philadelphia, University of Pennsylvania,...
Global First Engineered Exosome with INCI Name -- ImmVira Leads a New Era in International Cosmetic Ingredients
SUZHOU, China, April 10, 2025 /PRNewswire/ -- EonveLab, a subsidiary of ImmVira Group ("ImmVira," or the "Company"), recently announced that its in-house developed engineered exosome product, MVR-EX103, developed for treating superficial skin...
Paranovus Entertainment Technology Limited Received Nasdaq Notification Letter Related to Late Filing of Form 6-K Reporting Interim Financial Information
NEW YORK, April 11, 2025 /PRNewswire/ -- Paranovus Entertainment Technology Limited ("PAVS" or the "Company"), (NASDAQ: PAVS) announced today that it has received a letter from the Nasdaq Stock Market LLC ("Nasdaq"), dated April 9, 2025 (the...
Yingli Pharma Announces Successful End-of-Phase 2 Meeting with FDA and Clearance of Global Multi-center Phase 3 Registration Study Design of Linperlisib for the Treatment of Relapsed and/or Refractory Peripheral T-cell Lymphoma
SAN FRANCISCO, April 1, 2025 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. (Yingli Pharma), a clinical stage biotechnology company developing oral small molecule drugs for cancer, metabolic, and immune diseases, announced today that it...
Odoo in Vietnam: Supporting SME Growth and Digital Transformation
HANOI, Vietnam, March 31, 2025 /PRNewswire/ -- Business management software Odoo wrapped up successful Business Shows themed "Explore and Grow Business Potential Through ERP System" in Hanoi and Ho Chi Minh City together with sponsoring partners A1...
AZI Received Nasdaq Notification Regarding Minimum Market Value Deficiency
BEIJING, March 28, 2025 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) ("Autozi" or the "Company"), a automotive products and services company in China, today announced that it has received written notification (the...